Cheviot Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 8:17 am

Quick Insight

Cheviot Company Ltd, operating in the jute/jute yarn/jute products industry, shows a promising intrinsic value with a share price of 1,191 and a market cap of 716 Cr. The company's P/E ratio of 12.0 indicates reasonable valuation, while ROE and ROCE stand at 7.75% and 10.0%, respectively, reflecting decent profitability and capital efficiency. With a healthy OPM of 15.38% and a robust ICR of 245.46x, Cheviot demonstrates strong operational performance and debt coverage. The significant promoter holding of 74.88% suggests a long-term commitment to the company. However, the lower P/BV ratio of 0.91x may indicate undervaluation, offering potential opportunities for investors to consider.

Competitors of Cheviot Company Ltd

All Competitor Stocks of Cheviot Company Ltd

Quarterly Result

Last Updated: August 19, 2025, 9:15 pm

Below is a detailed analysis of the quarterly data for Cheviot Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 120.00 Cr.. The value appears to be declining and may need further review. It has decreased from 134.00 Cr. (Mar 2025) to 120.00 Cr., marking a decrease of 14.00 Cr..
• For Expenses, as of Jun 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 113.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 13.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 17.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from -6.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 24.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 23.00 Cr..
• For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 20.00%, marking a decrease of 10.00%.
• For Net Profit, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 20.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 47.72. The value appears strong and on an upward trend. It has increased from 15.47 (Mar 2025) to 47.72, marking an increase of 32.25.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:15 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:34 pm

Below is a detailed analysis of the balance sheet data for Cheviot Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 645.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2024) to 645.00 Cr., marking an increase of 25.00 Cr..
• For Borrowings, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 9.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 46.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 10.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 713.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 681.00 Cr. (Mar 2024) to 713.00 Cr., marking an increase of 32.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 22.00 Cr..
• For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 311.00 Cr.. The value appears to be declining and may need further review. It has decreased from 321.00 Cr. (Mar 2024) to 311.00 Cr., marking a decrease of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 170.00 Cr.. The value appears strong and on an upward trend. It has increased from 153.00 Cr. (Mar 2024) to 170.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Mar 2025, the value is 713.00 Cr.. The value appears strong and on an upward trend. It has increased from 681.00 Cr. (Mar 2024) to 713.00 Cr., marking an increase of 32.00 Cr..

Notably, the Reserves (645.00 Cr.) exceed the Borrowings (7.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Key Financial Ratios

After reviewing the key financial ratios for Cheviot Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 98.08. This value is within the healthy range. It has decreased from 115.33 (Mar 24) to 98.08, marking a decrease of 17.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 98.08. This value is within the healthy range. It has decreased from 115.33 (Mar 24) to 98.08, marking a decrease of 17.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 110.19. This value is within the healthy range. It has decreased from 126.24 (Mar 24) to 110.19, marking a decrease of 16.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,113.60. It has increased from 1,039.44 (Mar 24) to 1,113.60, marking an increase of 74.16.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,113.60. It has increased from 1,039.44 (Mar 24) to 1,113.60, marking an increase of 74.16.
• For Dividend / Share (Rs.), as of Mar 25, the value is 5.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 751.75. It has decreased from 768.72 (Mar 24) to 751.75, marking a decrease of 16.97.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 140.46. This value is within the healthy range. It has decreased from 152.61 (Mar 24) to 140.46, marking a decrease of 12.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 129.06. This value is within the healthy range. It has decreased from 141.64 (Mar 24) to 129.06, marking a decrease of 12.58.
• For PBT / Share (Rs.), as of Mar 25, the value is 128.48. This value is within the healthy range. It has decreased from 141.03 (Mar 24) to 128.48, marking a decrease of 12.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 98.78. This value is within the healthy range. It has decreased from 115.26 (Mar 24) to 98.78, marking a decrease of 16.48.
• For PBDIT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. It has decreased from 19.85 (Mar 24) to 18.68, marking a decrease of 1.17.
• For PBIT Margin (%), as of Mar 25, the value is 17.16. This value is within the healthy range. It has decreased from 18.42 (Mar 24) to 17.16, marking a decrease of 1.26.
• For PBT Margin (%), as of Mar 25, the value is 17.09. This value is within the healthy range. It has decreased from 18.34 (Mar 24) to 17.09, marking a decrease of 1.25.
• For Net Profit Margin (%), as of Mar 25, the value is 13.14. This value exceeds the healthy maximum of 10. It has decreased from 14.99 (Mar 24) to 13.14, marking a decrease of 1.85.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.87. This value is below the healthy minimum of 15. It has decreased from 11.08 (Mar 24) to 8.87, marking a decrease of 2.21.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.12. This value is within the healthy range. It has decreased from 13.32 (Mar 24) to 11.12, marking a decrease of 2.20.
• For Return On Assets (%), as of Mar 25, the value is 8.09. This value is within the healthy range. It has decreased from 10.19 (Mar 24) to 8.09, marking a decrease of 2.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 0.71 (Mar 24) to 0.63, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 5.70. This value exceeds the healthy maximum of 3. It has increased from 4.89 (Mar 24) to 5.70, marking an increase of 0.81.
• For Quick Ratio (X), as of Mar 25, the value is 2.20. This value exceeds the healthy maximum of 2. It has decreased from 2.28 (Mar 24) to 2.20, marking a decrease of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 4. It has decreased from 2.50 (Mar 24) to 2.03, marking a decrease of 0.47.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 23.41 (Mar 24) to 0.00, marking a decrease of 23.41.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 21.37 (Mar 24) to 0.00, marking a decrease of 21.37.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 76.59 (Mar 24) to 0.00, marking a decrease of 76.59.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 78.63 (Mar 24) to 0.00, marking a decrease of 78.63.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 245.46. This value is within the healthy range. It has decreased from 249.94 (Mar 24) to 245.46, marking a decrease of 4.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 173.62. This value is within the healthy range. It has decreased from 189.78 (Mar 24) to 173.62, marking a decrease of 16.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 586.82. It has decreased from 761.20 (Mar 24) to 586.82, marking a decrease of 174.38.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.34, marking a decrease of 0.30.
• For EV / EBITDA (X), as of Mar 25, the value is 7.15. This value is within the healthy range. It has decreased from 8.28 (Mar 24) to 7.15, marking a decrease of 1.13.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.35, marking a decrease of 0.28.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 76.58 (Mar 24) to 0.00, marking a decrease of 76.58.
• For Price / BV (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.21 (Mar 24) to 0.91, marking a decrease of 0.30.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.35, marking a decrease of 0.28.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness